» Articles » PMID: 23546566

Empirical Evidence of the Importance of Comparative Studies of Diagnostic Test Accuracy

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2013 Apr 3
PMID 23546566
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systematic reviews that "compare" the accuracy of 2 or more tests often include different sets of studies for each test.

Purpose: To investigate the availability of direct comparative studies of test accuracy and to assess whether summary estimates of accuracy differ between meta-analyses of noncomparative and comparative studies.

Data Sources: Systematic reviews in any language from the Database of Abstracts of Reviews of Effects and the Cochrane Database of Systematic Reviews from 1994 to October 2012.

Study Selection: 1 of 2 assessors selected reviews that evaluated at least 2 tests and identified meta-analyses that included both noncomparative studies and comparative studies.

Data Extraction: 1 of 3 assessors extracted data about review and study characteristics and test performance.

Data Synthesis: 248 reviews compared test accuracy; of the 6915 studies, 2113 (31%) were comparative. Thirty-six reviews (with 52 meta-analyses) had adequate studies to compare results of noncomparative and comparative studies by using a hierarchical summary receiver-operating characteristic meta-regression model for each test comparison. In 10 meta-analyses, noncomparative studies ranked tests in the opposite order of comparative studies. A total of 25 meta-analyses showed more than a 2-fold discrepancy in the relative diagnostic odds ratio between noncomparative and comparative studies. Differences in accuracy estimates between noncomparative and comparative studies were greater than expected by chance (P < 0.001).

Limitation: A paucity of comparative studies limited exploration of direction in bias.

Conclusion: Evidence derived from noncomparative studies often differs from that derived from comparative studies. Robustly designed studies in which all patients receive all tests or are randomly assigned to receive one or other of the tests should be more routinely undertaken and are preferred for evidence to guide test selection.

Primary Funding Source: National Institute for Health Research (United Kingdom).

Citing Articles

GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease.

Aralica M, Nadarevic T, Colli A, Casazza G, Vranic L, Fraquelli M Cochrane Database Syst Rev. 2024; 12():CD015826.

PMID: 39688172 PMC: 11650702. DOI: 10.1002/14651858.CD015826.


Joint meta-analysis of two diagnostic tests accounting for within and between studies dependence.

Nikoloulopoulos A Stat Methods Med Res. 2024; 33(10):1800-1817.

PMID: 39262159 PMC: 11577699. DOI: 10.1177/09622802241269645.


A review of methods for the analysis of diagnostic tests performed in sequence.

Fanshawe T, Nicholson B, Perera R, Oke J Diagn Progn Res. 2024; 8(1):8.

PMID: 39223640 PMC: 11370044. DOI: 10.1186/s41512-024-00175-3.


Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocol.

Sadler L, Jones H, Whiting P, Rogers M, Watt K, Cramp M NIHR Open Res. 2024; 3:23.

PMID: 39139275 PMC: 11320044. DOI: 10.3310/nihropenres.13409.2.


Comment on "An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases": appealing results, but caution is still necessary.

He S, Zeng H Int J Clin Pharm. 2024; 46(4):996-997.

PMID: 38896392 DOI: 10.1007/s11096-024-01764-4.